It is a five-year agreement that was effective upon approval by Pfizer’s Board of Directors on February 21, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback